GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 77 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $346,000 | -95.0% | 24,365 | -97.2% | 0.00% | -97.4% |
| Q3 2015 | $6,885,000 | -40.7% | 874,820 | -31.7% | 0.04% | -26.9% |
| Q2 2015 | $11,605,000 | -1.7% | 1,280,889 | +40.8% | 0.05% | -1.9% |
| Q1 2015 | $11,807,000 | +13471.3% | 909,621 | +10272.0% | 0.05% | – |
| Q1 2014 | $87,000 | -23.7% | 8,770 | +2.5% | 0.00% | -100.0% |
| Q4 2013 | $114,000 | +50.0% | 8,560 | +36.2% | 0.00% | – |
| Q3 2013 | $76,000 | – | 6,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 500,000 | $6,765,000 | 5.83% |
| Gruss & Co., LLC | 200,000 | $2,706,000 | 3.07% |
| First Light Asset Management, LLC | 150,076 | $2,031,000 | 1.37% |
| Curi RMB Capital, LLC | 1,032,369 | $13,968,000 | 0.88% |
| Camber Capital Management LP | 908,100 | $12,287,000 | 0.80% |
| CADIAN CAPITAL MANAGEMENT, LP | 887,500 | $12,008,000 | 0.36% |
| PARNASSUS INVESTMENTS, LLC | 2,118,127 | $28,658,000 | 0.25% |
| Visium Asset Management, LP | 786,468 | $10,641,000 | 0.16% |
| PUTNAM INVESTMENTS LLC | 5,198,367 | $70,333,000 | 0.15% |
| Capital Impact Advisors, LLC | 13,933 | $189,000 | 0.14% |